Here are three notes.
1. Analysts gave AmSurg shares a $94.33 price target
2. The shares have a rating of 1.2, indicating a “buy” rating.
3. During the most recent quarter, AmSurg’s earnings per share totaled $1.01.
More articles on surgery centers:
Analysts give SCA a $53.15 price target — 6 notes
CHI St. Luke’s pursues ASC expansion plans in Houston, acquires & rebrands Woodlands Ambulatory Surgery Center — 4 key takeaways
Nobilis shares rally 45.6% in 3 months — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.